Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Women with Down syndrome show more advanced Alzheimer's signs at diagnosis

Women with Down syndrome show more advanced Alzheimer's signs at diagnosis

Cats with dementia show brain changes similar to Alzheimer’s in humans

Cats with dementia show brain changes similar to Alzheimer’s in humans

Study establishes a causal link between mitochondrial dysfunction and neurodegenerative diseases

Study establishes a causal link between mitochondrial dysfunction and neurodegenerative diseases

New insights into how keto diet can restore cognitive function following status epilepticus

New insights into how keto diet can restore cognitive function following status epilepticus

Alzheimer’s research reaches a critical tipping point

Alzheimer’s research reaches a critical tipping point

Uncovering the secrets of ‘SuperAgers’ and cognitive longevity

Uncovering the secrets of ‘SuperAgers’ and cognitive longevity

Scientists link brain lithium loss to early Alzheimer’s changes

Scientists link brain lithium loss to early Alzheimer’s changes

New antibody delivery system boosts Alzheimer's treatment in mice

New antibody delivery system boosts Alzheimer's treatment in mice

New microscope system reveals molecular activity deep in the brain tissue

New microscope system reveals molecular activity deep in the brain tissue

Cedars-Sinai study finds new way to combat Alzheimer’s in preclinical models

Cedars-Sinai study finds new way to combat Alzheimer’s in preclinical models

UC Irvine researchers discover naturally occurring compounds to rejuvenate aging brain cells

UC Irvine researchers discover naturally occurring compounds to rejuvenate aging brain cells

Stress internalization increases risk of age-related cognitive decline in Chinese seniors

Stress internalization increases risk of age-related cognitive decline in Chinese seniors

Nighttime caffeine linked to increased impulsivity

Nighttime caffeine linked to increased impulsivity

Researchers discover amyloid protein buildup in bone marrow of aging mice

Researchers discover amyloid protein buildup in bone marrow of aging mice

KAIST scientists achieve first total synthesis of herpotrichone with neuroprotective properties

KAIST scientists achieve first total synthesis of herpotrichone with neuroprotective properties

New brainwave marker identified for Alzheimer’s detection

New brainwave marker identified for Alzheimer’s detection

New research unveils vast influence of B vitamins on health and disease

New research unveils vast influence of B vitamins on health and disease

Johns Hopkins uncovers protein's unexpected role in brain signaling

Johns Hopkins uncovers protein's unexpected role in brain signaling

Researchers trace metabolic superpowers of hibernators to shared DNA

Researchers trace metabolic superpowers of hibernators to shared DNA

Synthetic torpor moves closer to real-world medical use

Synthetic torpor moves closer to real-world medical use

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.